Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,604.50
Bid: 1,604.00
Ask: 1,604.50
Change: -5.50 (-0.34%)
Spread: 0.50 (0.031%)
Open: 1,611.50
High: 1,615.50
Low: 1,599.50
Prev. Close: 1,610.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Friday broker round-up UPDATE

Fri, 22nd Feb 2013 07:12

Antofagasta: RBC upgrades from underperform to outperform.Ashmore Group: Citigroup raises target price from 330p to 355p upgrading to neutral. JP Morgan ups target price from 361p to 413p and maintains a neutral rating.Babcock International: Citigroup revises target price from 965p to 1185p and keeps its buy recommendation.BAE Systems: Deutsche Bank takes target price from 360p to 375p maintaining a buy recommendation. JP Morgan increases target price from 330p to 360p and retains a neutral rating.Barclays: Investec shifts target price from 340p to 345p and upgrades from hold to buy.BP: Canaccord Genuity downgrades from buy to hold with a target price of 500p.Bumi: JP Morgan reiterates underweight. Liberum reinitiates coverage at buy.British Sky Broadcasting: HSBC ups target price from 520p to 600p keeping an underweight rating.Capita Group: Citigroup moves target price from 870p to 990p, while leaving its buy recommendation unchanged.Chariot Oil & Gas: Jefferies ups target price from 36p to 50p and upgrades from hold to buy. Merchant Securities cuts target price from 29.20p to 20.60p, while reiterating a hold recommendation.CSR: UBS raises target price from 330p to 450p, while retaining a neutral rating. Deutsche Bank revises target price from 255p to 300p, while staying with its sell recommendation. JP Morgan takes target price from 450p to 475p and reiterates an overweight rating. Canaccord Genuity moves target price from 370p to 475p and keeps a buy recommendation.Drax Group: Goldman Sachs downgrades from buy to neutral.Filtrona: UBS increases target price from 600p to 660p and keeps a buy recommendation.Fresnillo: Societe Generale initiates with a target price of 1200p and a sell recommendation.GlaxoSmithKline: Jefferies moves target price from 1500p to 1550p and maintains a hold recommendation.Go-Ahead Group: HSBC revises target price from 1415p to 1485p, while staying with an overweight rating.G4S: HSBC shifts target price from 260p to 270p and downgrades to underweight.Halfords Group: UBS lowers target price from 290p to 280p and retains a sell recommendation.HSBC Holdings: Credit Suisse moves target price from 750p to 760p and keeps an outperform rating.Informa: Deutsche Bank shifts target price from 600p to 620p and leaves its buy recommendation unaltered. Citigroup takes target price from 520p to 550p reiterating a buy rating. Westhouse Securities ups target price from 493p to 525p and upgrades from neutral to add. Canaccord Genuity raises target price from 500p to 560p maintaining its buy recommendation. Investec increases target price from 495p to 520p keeping a hold recommendation.InterContinental Hotels Group: Citigroup increases target price from 1900p to 2200p retaining its buy recommendation.Interserve: Westhouse Securities raises target price from 432p to 537p, while downgrading from buy to add.Johnson Matthey: Morgan Stanley reduces target price form 2300p to 2200p retaining an underweight rating.Kingfisher: HSBC cuts target price from 340p to 335p and keeps its overweight rating.Lancashire: Nomura increases target price from 826p to 906p not altering its neutral rating.Millennium & Copthome: Credit Suisse moves target price from 524p to 542p and retains its neutral rating.Mondi: UBS ups target price from 720p to 840p, while leaving its neutral rating unchanged.Netplay: Merchant Securities initiates with a target price of 20p and a buy recommendation.New World Resources: JP Morgan shifts target price from 150p to 160p leaving its underweight rating unaltered.Old Mutual: JP Morgan raises target price from 186p to 209p, while downgrading to neutral.Pendragon: Panmure Gordon shifts target price from 15p to 19p and still recommends selling.Restaurant Group: Citigroup revises target price from 400p to 450p, while the buy recommendation is kept.REXAM: Credit Suisse shifts target price from 545p to 555p and stays with its neutral rating. Oriel Securities ups target prcie from 540p to 570p maintaining a buy recommendation.Sainsbury: Citigroup raises target price from 315p to 385p upgrading to buy.Serco Group: Citigroup shifts target price from 670p to 680p reiterating a buy recommendation.Shire: Morgan Stanley moves target price from 2350p to 2400p keeping an overweight rating.Spectris: N+1 Singer takes target price from 2135p to 2415p, while reiterating a hold recommendation. Investec ups target price from 2400p to 2575p and stays with its hold rating.Sports Direct International: Citigroup increases target price from 470p to 530p and still recommends buying.Whitbread: Citigroup raises target price from 2400p to 2675p and leaves its neutral rating unchanged. JP Morgan revises target price from 2650p to 2700p maintaining an overweight rating. Panmure Gordon ups target price from 1994p to 2500p, while reiterating a hold recommendation.William Hill: Jefferies raises target price from 370p to 500p keeping a buy recommendation.Xaar: Investec starts with a target price of 350p and a buy recommendation.
More News
11 Jun 2024 14:31

Zantac litigation fears overdone at GSK, says Shore Capital

(Sharecast News) - Volatile moves in GSK's share price are likely to persist in the near term as a result of ongoing Zantac-related litigation, but the long-term investment case is "still appealing", according to Shore Capital, which kept a 'buy' rating on the stock.

Read more
11 Jun 2024 09:32

TOP NEWS: GSK takes first steps to appeal Zantac ruling in Delaware

(Alliance News) - GSK PLC on Tuesday said it has taken the first steps to seek appeal of a ruling by the Delaware Superior Court in regard to its discontinued heartburn drug Zantac.

Read more
11 Jun 2024 09:12

LONDON MARKET OPEN: FTSE 100 up; UK unemployment rises to 4.4%

(Alliance News) - Stock prices in London opened higher on Tuesday, after a difficult day for markets on Monday amid the EU election fallout.

Read more
11 Jun 2024 07:52

LONDON BRIEFING: FTSE 100 called up despite unemployment rise

(Alliance News) - The FTSE 100 in London was called to open higher on Tuesday, after data showed that unemployment in the UK unexpectedly rose.

Read more
11 Jun 2024 07:22

GSK launches appeal to recent Zantac ruling

(Sharecast News) - GSK has started the process of appealing a recent decision by the Delaware Superior Court regarding the ongoing Zantac, or ranitidine, litigation, it announced on Tuesday.

Read more
11 Jun 2024 00:32

GSK asks to appeal Delaware ruling allowing Zantac cases to go forward

June 10 (Reuters) -

Read more
10 Jun 2024 22:49

Latest trial over Zantac cancer claims called off as plaintiff drops case

June 10 (Reuters) - A woman who claimed in a lawsuit that GSK's discontinued heartburn drug Zantac caused her breast cancer dropped her case shortly before it was set to go to trial in Illinois state court on Monday, the company announced.

Read more
10 Jun 2024 19:00

TOP NEWS: GSK welcomes dismissal of Zantac case in Illinois

(Alliance News) - GSK PLC on Monday welcomed the dismissal of a case in the US concerning the heartburn drug, Zantac, which was due to start on Monday.

Read more
10 Jun 2024 12:42

EU to secure 40 million avian flu vaccines for 15 countries - officials

BRUSSELS, June 10 (Reuters) - The EU will sign a contract on Tuesday to secure over 40 million doses of a preventative avian flu vaccine for 15 countries with the first shipments heading to Finland, EU officials said on Monday.

Read more
10 Jun 2024 08:39

GSK gets FDA approval for Arexvy vax in 50-59 year olds at risk of RSV

(Alliance News) - GSK PLC on Monday announced that the US Food & Drug Administration has approved an expanded age indication for its respiratory syncytial virus vaccine.

Read more
10 Jun 2024 07:37

LONDON BRIEFING: FTSE called down amid political uncertainty in EU

(Alliance News) - Stocks in London are called to open lower on Monday, setting off the week on the backfoot, with eyes on the US Federal Reserve's latest interest rate decision.

Read more
10 Jun 2024 07:17

GSK's Arexvy vaccine approved for wider age range

(Sharecast News) - US regulators have approved the use of GSK's Arexvy vaccine for a younger age group, the biopharma group announced on Monday.

Read more
7 Jun 2024 19:34

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, June 7 (Reuters) - The outbreak of bird flu in U.S. dairy cows has now been confirmed in Minnesota and Iowa, bringing to 11 the total number of affected states, which have been encouraged to ramp up testing efforts at the request of government officials.

Read more
5 Jun 2024 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
3 Jun 2024 17:20

European shares kick-off June on a high note in anticipation of ECB rate cut

GSK tumbles as Zantac lawsuits allowed to proceed

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.